
Gustavo A. Rosario Benitez
Examiner (ID: 599, Phone: (571)270-7888 , Office: P/2838 )
| Most Active Art Unit | 2838 |
| Art Unit(s) | 2838 |
| Total Applications | 811 |
| Issued Applications | 625 |
| Pending Applications | 91 |
| Abandoned Applications | 129 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 483632
[patent_doc_number] => 07220825
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => 'Polypeptide useful for a non-invasive test for inflammatory bowel disease'
[patent_app_type] => utility
[patent_app_number] => 10/652666
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2125
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220825.pdf
[firstpage_image] =>[orig_patent_app_number] => 10652666
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/652666 | Polypeptide useful for a non-invasive test for inflammatory bowel disease | Aug 28, 2003 | Issued |
Array
(
[id] => 7045138
[patent_doc_number] => 20050249733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Mammalian proteases; related reagents'
[patent_app_type] => utility
[patent_app_number] => 10/652893
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21803
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20050249733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10652893
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/652893 | Mammalian proteases; related reagents | Aug 28, 2003 | Abandoned |
Array
(
[id] => 363623
[patent_doc_number] => 07482436
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-27
[patent_title] => 'Human antihuman interleukin-6 antibody and fragment of antibody'
[patent_app_type] => utility
[patent_app_number] => 10/526072
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3501
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/482/07482436.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526072
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526072 | Human antihuman interleukin-6 antibody and fragment of antibody | Aug 27, 2003 | Issued |
Array
(
[id] => 7285838
[patent_doc_number] => 20040146503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Methods and compositions for inducing stable immune tolerance'
[patent_app_type] => new
[patent_app_number] => 10/653012
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7700
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10653012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/653012 | Methods and compositions for inducing stable immune tolerance | Aug 27, 2003 | Abandoned |
Array
(
[id] => 7371920
[patent_doc_number] => 20040219140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Compositions and methods for preventing platelet aggregation'
[patent_app_type] => new
[patent_app_number] => 10/468579
[patent_app_country] => US
[patent_app_date] => 2003-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2243
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468579 | Compositions and methods for preventing platelet aggregation | Aug 20, 2003 | Abandoned |
Array
(
[id] => 7252361
[patent_doc_number] => 20040259196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'T cell receptor variants expressed in mesenchymal cells and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/642642
[patent_app_country] => US
[patent_app_date] => 2003-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12227
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642642
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642642 | T cell receptor variants expressed in mesenchymal cells and uses thereof | Aug 18, 2003 | Abandoned |
Array
(
[id] => 5759618
[patent_doc_number] => 20060210563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Administration of anti-cytokine f(ab\')2 antibody fragments'
[patent_app_type] => utility
[patent_app_number] => 10/565885
[patent_app_country] => US
[patent_app_date] => 2003-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8036
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565885 | Administration of anti-cytokine f(ab')2 antibody fragments | Jul 24, 2003 | Abandoned |
Array
(
[id] => 9041148
[patent_doc_number] => 20130243786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS (JRA)'
[patent_app_type] => utility
[patent_app_number] => 10/623318
[patent_app_country] => US
[patent_app_date] => 2003-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22501
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10623318
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/623318 | TREATMENT OF JUVENILE RHEUMATOID ARTHRITIS (JRA) | Jul 17, 2003 | Abandoned |
Array
(
[id] => 314969
[patent_doc_number] => 07524939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Antibodies that bind to and inhibit human cytochrome P450 2C9*1, 2C9*2, and 2C9*3'
[patent_app_type] => utility
[patent_app_number] => 10/616760
[patent_app_country] => US
[patent_app_date] => 2003-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11870
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524939.pdf
[firstpage_image] =>[orig_patent_app_number] => 10616760
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/616760 | Antibodies that bind to and inhibit human cytochrome P450 2C9*1, 2C9*2, and 2C9*3 | Jul 8, 2003 | Issued |
Array
(
[id] => 455639
[patent_doc_number] => 07244410
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-17
[patent_title] => 'Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 10/616187
[patent_app_country] => US
[patent_app_date] => 2003-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 27170
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244410.pdf
[firstpage_image] =>[orig_patent_app_number] => 10616187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/616187 | Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis | Jul 8, 2003 | Issued |
Array
(
[id] => 7358604
[patent_doc_number] => 20040014126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/611945
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 21530
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014126.pdf
[firstpage_image] =>[orig_patent_app_number] => 10611945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/611945 | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | Jul 2, 2003 | Abandoned |
Array
(
[id] => 7361689
[patent_doc_number] => 20040014666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/606366
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19007
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014666.pdf
[firstpage_image] =>[orig_patent_app_number] => 10606366
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/606366 | Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof | Jun 25, 2003 | Abandoned |
Array
(
[id] => 7269438
[patent_doc_number] => 20040057956
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Inotropic antibodies and therapeutic uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/607583
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15205
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20040057956.pdf
[firstpage_image] =>[orig_patent_app_number] => 10607583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/607583 | Inotropic antibodies and therapeutic uses thereof | Jun 24, 2003 | Issued |
Array
(
[id] => 7389953
[patent_doc_number] => 20040037826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Combined use of a modulator of CD3 and a GLP-1 compound'
[patent_app_type] => new
[patent_app_number] => 10/462490
[patent_app_country] => US
[patent_app_date] => 2003-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5966
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462490
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462490 | Combined use of a modulator of CD3 and a GLP-1 compound | Jun 15, 2003 | Abandoned |
Array
(
[id] => 7312078
[patent_doc_number] => 20040033232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Methods and compositions for in vivo clearance of pathogens'
[patent_app_type] => new
[patent_app_number] => 10/459771
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12340
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033232.pdf
[firstpage_image] =>[orig_patent_app_number] => 10459771
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/459771 | Methods and compositions for in vivo clearance of pathogens | Jun 11, 2003 | Abandoned |
Array
(
[id] => 7384893
[patent_doc_number] => 20040029554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Method for histocompatibility testing'
[patent_app_type] => new
[patent_app_number] => 10/297296
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5926
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029554.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297296
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297296 | Method for histocompatibility testing | Jun 11, 2003 | Abandoned |
Array
(
[id] => 7389799
[patent_doc_number] => 20040037808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Methods for modulating T cell responses by manipulating a commom cytokine receptor gamma-chain'
[patent_app_type] => new
[patent_app_number] => 10/458069
[patent_app_country] => US
[patent_app_date] => 2003-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12351
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10458069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/458069 | Methods for modulating T cell responses by manipulating a commom cytokine receptor gamma-chain | Jun 9, 2003 | Abandoned |
Array
(
[id] => 7406399
[patent_doc_number] => 20040024185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'NF-AT-interacting protein NIP45 and methods of use therefor'
[patent_app_type] => new
[patent_app_number] => 10/448748
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18568
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20040024185.pdf
[firstpage_image] =>[orig_patent_app_number] => 10448748
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/448748 | NF-AT-interacting protein NIP45 and methods of use therefor | May 29, 2003 | Abandoned |
Array
(
[id] => 7269896
[patent_doc_number] => 20040058414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Humanized immunoglobulins'
[patent_app_type] => new
[patent_app_number] => 10/452357
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 62045
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058414.pdf
[firstpage_image] =>[orig_patent_app_number] => 10452357
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/452357 | Humanized immunoglobulins | May 29, 2003 | Abandoned |
Array
(
[id] => 7378942
[patent_doc_number] => 20040028677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Chimeric allograft tolerance induction, monitoring and maintenance'
[patent_app_type] => new
[patent_app_number] => 10/443281
[patent_app_country] => US
[patent_app_date] => 2003-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16896
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20040028677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10443281
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/443281 | Chimeric allograft tolerance induction, monitoring and maintenance | May 21, 2003 | Abandoned |